How Do Physicians Approach Intravenous Alteplase Treatment in Patients with Acute Ischemic Stroke Who Are Eligible for Intravenous Alteplase and Endovascular Therapy? Insights from UNMASK-EVT

References

1. 1.↵
   1. Goyal M,
   2. Menon BK,
   3. van Zwam WH, et al

   ; HERMES Collaborators. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 2016;387:1723–31 doi:10.1016/S0140-6736(16)00163-X pmid:26898852

   CrossRefPubMed
2. 2.↵
   1. Campbell BC,
   2. Meretoja A,
   3. Donnan GA, et al

   . Twenty-year history of the evolution of stroke thrombolysis with intravenous alteplase to reduce long-term disability. Stroke 2015;46:2341–46 doi:10.1161/STROKEAHA.114.007564 pmid:26152294

   FREE Full Text
3. 3.↵
   1. Menon BK,
   2. Al-Ajlan FS,
   3. Najm M, et al

   ; INTERRSeCT Study Investigators. Association of clinical, imaging, and thrombus characteristics with recanalization of visible intracranial occlusion in patients with acute ischemic stroke. JAMA 2018;320:1017–26 doi:10.1001/jama.2018.12498 pmid:30208455

   CrossRefPubMed
4. 4.↵
   1. Campbell BC,
   2. Mitchell PJ,
   3. Churilov L, et al

   ; EXTEND-IA TNK Investigators. Tenecteplase versus alteplase before thrombectomy for ischemic stroke. N Engl J Med 2018;378:1573–82 doi:10.1056/NEJMoa1716405 pmid:29694815

   CrossRefPubMed
5. 5.↵
   1. Goyal M,
   2. Demchuk AM,
   3. Menon BK, et al

   ; ESCAPE Trial Investigators. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 2015;372:1019–30 doi:10.1056/NEJMoa1414905 pmid:25671798

   CrossRefPubMed
6. 6.↵
   1. Desilles JP,
   2. Loyau S,
   3. Syvannarath V, et al

   . Alteplase reduces downstream microvascular thrombosis and improves the benefit of large artery recanalization in stroke. Stroke 2015;46:3241–48 doi:10.1161/STROKEAHA.115.010721 pmid:26443832

   Abstract/FREE Full Text
7. 7.↵
   1. Saposnik GM,
   2. Kashani N,
   3. Wilson AT, et al

   . Factors associated with the decision-making on endovascular thrombectomy for the management of acute ischemic stroke. Stroke 2019;50:2441–47 doi:10.1161/STROKEAHA.119.025631 pmid:31327314

   CrossRefPubMed
8. 8.↵
   1. Powers WJ,
   2. Rabinstein AA,
   3. Ackerson T, et al

   ; American Heart Association Stroke Council. 2018 Guidelines for the Early Management of Patients with Acute Ischemic Stroke: A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke 2018;49:e46–110 doi:10.1161/STR.0000000000000158 pmid:29367334

   Abstract/FREE Full Text
9. 9.↵
   1. Mueller L,
   2. Pult F,
   3. Meisterernst J, et al

   . Impact of intravenous thrombolysis on recanalization rates in patients with stroke treated with bridging therapy. Eur J Neurol 2017;24:1016–21 doi:10.1111/ene.13330 pmid:28649759

   CrossRefPubMed
10. 10.↵
    1. Seners P,
    2. Turc G,
    3. Maier B, et al

    . Incidence and predictors of early recanalization after intravenous thrombolysis: a systematic review and meta-analysis. Stroke 2016;47:2409–12 doi:10.1161/STROKEAHA.116.014181 pmid:27462117

    Abstract/FREE Full Text
11. 11.↵
    1. Guedin P,
    2. Larcher A,
    3. Decroix JP, et al

    . Prior IV thrombolysis facilitates mechanical thrombectomy in acute ischemic stroke. J Stroke Cerebrovasc Dis 2015;24:952–57 doi:10.1016/j.jstrokecerebrovasdis.2014.12.015 pmid:25804567

    CrossRefPubMed
12. 12.↵
    1. Davalos A,
    2. Pereira VM,
    3. Chapot R, et al

    ; Solitaire Group. Retrospective multicenter study of Solitaire FR for revascularization in the treatment of acute ischemic stroke. Stroke 2012;43:2699–705 doi:10.1161/STROKEAHA.112.663328 pmid:22851547

    Abstract/FREE Full Text
13. 13.↵
    1. Choi PM,
    2. Desai JA,
    3. Kashyap D, et al

    . Are all stroke patients eligible for fast alteplase treatment? An analysis of unavoidable delays. Acad Emerg Med 2016;23:393–99 doi:10.1111/acem.12914 pmid:26824684

    CrossRefPubMed
14. 14.↵
    1. Dhaliwal J,
    2. Ferrigno B,
    3. Abiola O, et al

    . Hospital-based intervention to reduce tPA administration time. Interdisciplinary Neurosurgery 2019;15:15–18. doi:10.1016/j.inat.2018.09.005

    CrossRef
15. 15.↵
    1. Kamal N,
    2. Sheng S,
    3. Xian Y, et al

    . Delays in door-to-needle times and their impact on treatment time and outcomes in Get with the Guidelines-Stroke. Stroke 2017;48:946–54 doi:10.1161/STROKEAHA.116.015712 pmid:28228574

    Abstract/FREE Full Text
16. 16.↵
    1. Mohamad NF,
    2. Hastrup S,
    3. Rasmussen M, et al

    . Bypassing primary stroke centre reduces delay and improves outcomes for patients with large vessel occlusion. Eur Stroke J 2016;1:85–92 doi:10.1177/2396987316647857 pmid:31008269

    CrossRefPubMed
17. 17.↵
    1. Wardlaw JM,
    2. Murray V,
    3. Berge E, et al

    . Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev 2014;7:CD000213 doi:10.1002/14651858.CD000213.pub3

    CrossRefPubMed
18. 18.↵
    1. Yaghi S,
    2. Eisenberger A,
    3. Willey JZ

    . Symptomatic intracerebral hemorrhage in acute ischemic stroke after thrombolysis with intravenous recombinant tissue plasminogen activator: a review of natural history and treatment. JAMA Neurol 2014;71:1181–85 doi:10.1001/jamaneurol.2014.1210 pmid:25069522

    CrossRefPubMed
19. 19.↵
    1. Rai AT,
    2. Boo S,
    3. Buseman C, et al

    . Intravenous thrombolysis before endovascular therapy for large vessel strokes can lead to significantly higher hospital costs without improving outcomes. J Neurointerv Surg 2018;10:17–21 doi:10.1136/neurintsurg-2016-012830 pmid:28062805

    Abstract/FREE Full Text